Trial intelligence / Profile preview

Mirogabalin vs Pregabalin in Total Knee Arthroplasty

NCT06328062Recruiting

Sponsor
Thammasat University Hospital
Start
Apr 2024
Primary completion
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of mirogabalin in postoperative pain (2 arms), sponsored by Thammasat University Hospital. Primary endpoint: Pain score at 12 weeks. Started Apr 2024; status: recruiting.

02

Drugs

mirogabalin
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06328062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06328062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call